Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Hilton, Coylumbridge, Aviemore, Scotland, 10–12 September 2008
01 REFINING NOVEL ASSOCIATIONS IN MULTIPLE SCLEROSIS
International Multiple Sclerosis Genetics Consortium. University of Cambridge
In a systematic genome-wide analysis of multiple sclerosis involving 12 360 individuals we identified three markers showing association with genome-wide significance (p>5.0E–7); one from IL7R gene (rs6897932) and two from the IL2RA gene (rs12722489/rs2104286). In each case the major allele modestly increases susceptibility to the disease (odds ratio ∼1.2). To replicate and refine these associations we typed all three variants in an additional 20 708 individuals from Caucasian populations within the IMSGC providing a total of 33,068 individuals for analysis (11 019 unrelated cases, 13 616 controls and 2811 trios giving 8433 individuals). All three associations were confirmed at high levels of significance (rs6897932 p = 1.21E–17; rs2104286 p = 2.38E–23; rs12722489 p = 2.24E–15) and we found no evidence for heterogeneity of effect across the populations studied.
Analysis at a genotypic level confirmed homozygosity for the risk allele conferred greater susceptibility than the heterozygote genotype. This extension analysis illustrates the value of data sets that are significantly larger than the 2000 cases and controls recommended as a minimum by the Wellcome Trust Case Control Consortium (WTCCC); and convincingly replicates the associations in the IL7R and IL2RA genes.
02 THE BRITISH NEUROLOGICAL SURVEILLANCE UNIT STUDY OF NEUROLOGICAL COMPLICATIONS IN BEHçET’S SYNDROME
D Kidd. Royal Free Hospital, London
During the 5 years beginning 2000 all cases of Behçet’s syndrome reported to the BNSU were studied. 52 patients fulfilled the inclusion criteria, consented and had sufficient clinical details and investigation results. There were 24 males. The mean age was 31 (8 to 51) years. 26 had previously been diagnosed with the disease and the remainder were diagnosed during investigation of the neurological syndrome.
40 presented with inflammatory syndromes; 15 patients had brain stem lesions, 13 presented with hemisphere lesions of whom 3 had stroke-like episodes, 2 tumefactive lesions and the remainder encephalopathy with cognitive changes; 6 had seizures. Six had spinal cord lesions and the remaining 7 …